Validation study of FEC followed by docetaxel as preoperative chemotherapy in primary beast cancer (JBCRG-02')
Phase 2
- Conditions
- Primary breast cancer
- Registration Number
- JPRN-C000000320
- Lead Sponsor
- Japan Breast Cancer Reaserch Group (JBCRG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Hypersensitivity for drugs Serious coexisting illness Active double cancer Bilateral breast cancer Male breast cancer Pregnant or postpartum wemen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety, clinical and pathological response
- Secondary Outcome Measures
Name Time Method Breast-conserving rate, disease-free survival